🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our team’s latest discovery: lncRNA H19 plays a crucial role in driving liver injury in alcohol-associated liver disease by disrupting the alternative splicing of a key enzyme in methionine metabolism. HEPATOLOGY Journal twtr.to/Ka6pJ

Curious about Phosphatidylethanol testing and its impact on post-liver transplant care? Follow along for insights on alcohol use, candidate selection, and outcomes! Hanna Blaney, MD, MPH

Registration is now OPEN! twtr.to/dE178 Join us and Dr. Becky McCullough at the GRC Meeting. Don’t miss out on engaging discussions and networking, all in a stunning coastal setting! @DrPMonga Pranoti Mandrekar Gordon Research Conferences Jasmohan Bajaj Ekihiro Seki Llorente Lab Wen-Xing Ding

New review by our group! Hepatology Communications Uncover how alcohol damages mitochondria, fueling liver disease progression in ALD. We dive deep into the intricate link between alcohol, mitochondria, and liver damage. Elliot Tapper journals.lww.com/hepcomm/fullte…

Captivating insights from Juan Pablo (JP) Arab, MD  : From predictive models to population health, the talk on ALD was a masterclass in advancing research to improve patient outcomes. #JHU AH meeting

Our commentary on Jasmohan Bajaj 's work twtr.to/1btcZ : only 37% of high-risk patients with alcohol use and high fibrosis scores are referred to hepatology. We should work to improve screening and referral practices! Paola Zuluaga Blanco twtr.to/37qdz

The power of concordant NITs for prediction of decompensation and liver-related mortality in ALD Out now in the 🎄🎅 issue of HEPATOLOGY Journal 👏ENTIRE issue dedicated to alcohol-related liver disease: journals.lww.com/hep/pages/curr…

Beyond grateful of the amazing ⁦AASLD⁩ #ALD Special Interest Group! Thanks for all your hard work and dedication to our patients! #ALDCure #LiverTwitter ⁦Doug Simonetto, MD⁩ ⁦Tiffany Wu, MD MS⁩ ⁦Liz Lee⁩ ⁦Suthat Liangpunsakul⁩ ⁦Gene Im⁩

Our Editorial Board Dinner at #TLM2024 #TLM24 AASLD AASLD Foundation AASLD President Exciting things ahead!

Vivian Gahtan Loyola's Department of Surgery Loyola Medicine NIAAA News Dr. Liz Kovacs CoPARC Another successful #AIRIG in the books. Thank you all for bringing such great ideas and enthusiasm today! NIAAA News

Conclusions of a statement of ALD EXPERTS on MetALD: 🔸"Met" should include >1 risk factor: alcohol itself favors metabolic syndrome. 🔸Alcohol thresholds need prospective studies including biomarkers. 🔸Trials testing therapies for MetALD are needed. t.ly/L2JWE

We are pleased to share our article Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. Now available online in Journal of Hepatology MATHURIN PHILIPPE #LiverTwitter #LiverX authors.elsevier.com/a/1kOr5cOnAUhQK

The GRC/GRS on Alcohol-induced End Organ Damage is coming up fast! There are registration spots still available and many opportunities for early-career researchers to meet experts in the field! Special thanks to NIAAA News for our R13 to support trainees and our generous donors!

🥃 Our new article in Alcohol Research AUD, ALD, and alcohol-related liver cancer mortality 📈rising in the US older adult, despite global declines 🔗 shorturl.at/Likyz Suthat Liangpunsakul Karn Wijarnpreecha Luis Antonio Díaz, MD Juan Pablo (JP) Arab, MD  Mazen Noureddin, MD, MHSc

Thank you Mazen Noureddin, MD, MHSc Juan Pablo (JP) Arab, MD  AASLD for the invite to speak on my favorite topic: endoscopic mgmt of #MASLD! Great multiD session w Ali Aminian on metabolic surgery and MASLD experts. Had an amazing time learning from all the experts in MASLD, MetALD, and ALD!

"New genetic clues to alcohol-associated hepatitis! 🍷🧬 Our exome-wide study identifies novel risk loci, shedding light on why some heavy drinkers develop severe liver disease while others don’t HEPATOLOGY Journal journals.lww.com/hep/fulltext/2…

Liver transplant saves lives in AH but is it confounding trial outcomes? Our new paper dives into how LT impacts endpoint selection in AH trials bit.ly/4iYN2yd @srcaWKrebs Allison Kwong Paul Kwo Dr. Bobby Brown DURECT Corporation Hepatology Communications Elliot Tapper

Moderated my first session today #DDW2025 🤩So grateful for the opportunity. We had a fantastic session session on practical treatment approaches for ALD with our experts Gene Im Lamia Haque Po-Hung (Victor) Chen Sasha Deutsch-Link, MD MSCR Suthat Liangpunsakul AASLD

Please join me for these incredible ALD sessions Digestive Disease Week! ⏰ 10 AM: Dr. Doug Simonetto, MD & I will moderate a research forum w excellent speakers on 💊 targeting ALD ⏰ 2 PM: Drs. Ashwani Singal & Suthat Liangpunsakul & I will moderate an expert panel on integrated care of ALD #ddw2025

I’m just going to say it: GI is great, but hepatology is 💗. The hepatology community and talking liver is like a second home. I always leave inspired with a full ❤️. 🙏 Juan Pablo (JP) Arab, MD  Luis Antonio Díaz, MD Lizzie Aby, MD Gene Im Suthat Liangpunsakul Saul Karpen Jeremy Louissaint AASLD President